Alzamend Neuro, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
4.83M
on 2026-07-31, from 76K on 2024-04-30 10-Q ↗
Earlier counts are adjusted for the 1-for-9 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
$3.0M
Ascendiant Capital Markets, agreement of 2026-03-06. The amount sold under this agreement is not stated apart in the 10-Q. 8-K ↗
Cash
4.4 quarters
$7.6M on 2026-07-31 ÷ $1.7M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 3 months to 2026-07-31 | At-the-market sales | 569,684 | market | not stated | 10-Q ↗ |